Since its inception, Trade Star Science and Technology Industry Group Co., Ltd., has taken it upon itself to promote innovation and development in the field of bio-pharmaceutical science and technology. The group is committed to building a diversified business platform with the health industry at its core. Relying on its profound industry background and strong resource integration capabilities, the group focuses on medical technology research and development and investment, industrial park construction and management, and incubation of entrepreneurial projects.
The group's investment strategy covers the entire lifecycle of pharmaceutical R&D and manufacturing enterprises, from angel rounds to Pre-IPO. It includes outstanding domestic and international pharmaceutical-related enterprises such as Yuankang Pharmaceutical, Bonasia, Nanjing Haina, Aibo Biotech, Nextpoint, and IMMUNORACLE. At the same time, the group has expanded into the fields of energy and technological innovation, such as Inner Mongolia Jiutai New Energy and Zhonghang Xi'fei, demonstrating the diversity and forward-looking nature of its business.
In terms of industrial park construction, the group has developed the Keanrui Health Industry Science and Innovation Park, a key planning project in Fangshan District, Beijing, covering an area of 75 acres with a planned construction area of 50,000 square meters. The park will become the new headquarters of the group, including administrative management centers, marketing management centers, business operation centers, R&D pilot bases, and employee cultural and sports activity bases. It will also provide other settled enterprises with a high-quality R&D environment, technical support, and financial support.
At the same time, the group is actively planning and preparing for the Nanjing Health Industry Park to further expand the group's scale and influence in the pharmaceutical industry. Trade Star Science and Technology Industry Group, through its business model of technology R&D and investment, industrial park construction and management, and innovative incubation, has formed an ecosystem that fosters mutual promotion and joint development, contributing to the sustainable innovation and industrialization process in the field of bio-pharmaceutical science and technology.
